TABLE OF CONTENTS
Volume 9, Issue 4 (December 2006)
Editorial
Report from London FREE
R S Kirby
Prostate Cancer Prostatic Dis 9: 365; doi:10.1038/sj.pcan.4500932
Research Highlights
Prostate News FREE
Prostate Cancer Prostatic Dis 9: 366-369; doi:10.1038/sj.pcan.4500929
Reviews
Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy
O Al-Salihi, A Mitra and H Payne
Prostate Cancer Prostatic Dis 9: 370-373; advance online publication, July 11, 2006; doi:10.1038/sj.pcan.4500893
Performance of tPSA and f/tPSA for prostate cancer in Chinese. A systematic review and meta-analysis
Y Wang, G Sun, J G Pan, Z J Guo and T Li
Prostate Cancer Prostatic Dis 9: 374-378; advance online publication, August 22, 2006; doi:10.1038/sj.pcan.4500906
Original Articles
Characterization of a method for profiling gene expression in cells recovered from intact human prostate tissue using RNA linear amplification
Y Ding, L Xu, S Chen, B D Jovanovic, I B Helenowski, D L Kelly, W J Catalona, X J Yang, M Pins, V Ananthanarayanan and R C Bergan
Prostate Cancer Prostatic Dis 9: 379-391; advance online publication, June 20, 2006; doi:10.1038/sj.pcan.4500888
Androgen deprivation therapy and cardiac function: effects of endurance training
D S Hydock, K Y Wonders, C M Schneider and R Hayward
Prostate Cancer Prostatic Dis 9: 392-398; advance online publication, June 20, 2006; doi:10.1038/sj.pcan.4500890
Notch signalling and voltage-gated Na+ channel activity in human prostate cancer cells: independent modulation of in vitro motility
N Scorey, S P Fraser, P Patel, C Pridgeon, M J Dallman and M B A Djamgoz
Prostate Cancer Prostatic Dis 9: 399-406; advance online publication, July 11, 2006; doi:10.1038/sj.pcan.4500894
Lycopene inhibits DNA synthesis in primary prostate epithelial cells in vitro and its administration is associated with a reduced prostate-specific antigen velocity in a phase II clinical study
N J Barber, X Zhang, G Zhu, R Pramanik, J A Barber, F L Martin, J D H Morris and G H Muir
Prostate Cancer Prostatic Dis 9: 407-413; advance online publication, September 19, 2006; doi:10.1038/sj.pcan.4500895
Myofibroblastic stromal reaction and expression of tenascin-C and laminin in prostate adenocarcinoma
D Tomas, M Ulamec, T Hudolin, S Bulimba
i
, M Belicza and B Krulin
Prostate Cancer Prostatic Dis 9: 414-419; advance online publication, May 2, 2006; doi:10.1038/sj.pcan.4500874
Persistently high levels of immunosuppressive cytokines in patients after radical prostatectomy
N Quatan, B Meyer, M Bailey and H Pandha
Prostate Cancer Prostatic Dis 9: 420-425; advance online publication, September 19, 2006; doi:10.1038/sj.pcan.4500899
Manganase superoxide dismutase polymorphism in chronic pelvic pain syndrome patients
E D Arisan, S Arisan, M C Kiremit, H Ti
li, T Ça
kurlu, N Palavan-Unsal and E Ergenekon
Prostate Cancer Prostatic Dis 9: 426-431; advance online publication, July 18, 2006; doi:10.1038/sj.pcan.4500900
Efficacy and tolerability of the dual 5
-reductase inhibitor, dutasteride, in the treatment of benign prostatic hyperplasia in African-American men
C G Roehrborn and P Ray
Prostate Cancer Prostatic Dis 9: 432-438; advance online publication, September 19, 2006; doi:10.1038/sj.pcan.4500911
High-intensity focused ultrasound therapy for clinically localized prostate cancer
H M Lee, J H Hong and H Y Choi
Prostate Cancer Prostatic Dis 9: 439-443; advance online publication, July 18, 2006; doi:10.1038/sj.pcan.4500901
Seminal prostasomes inhibit the angiogenesis activity of rat aortic rings
G H Delves, A Goyal, B A Lwaleed and A J Cooper
Prostate Cancer Prostatic Dis 9: 444-447; advance online publication, July 11, 2006; doi:10.1038/sj.pcan.4500896
Case Report
De novo calcification of liver and nodal metastases in prostate carcinoma
P Ghosh, A C Santosa, G Y Lin and T M Downs
Prostate Cancer Prostatic Dis 9: 448-451; advance online publication, May 9, 2006; doi:10.1038/sj.pcan.4500875
Abstracts
British Prostate Group Autumn Meeting 2005 FREE
Prostate Cancer Prostatic Dis 9: 452-460; doi:10.1038/sj.pcan.4500904
